Equity Profile

LIVN

LivaNova PLC

Health CareHealth Care Equipment$4.6B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

LivaNova PLC is a health care company that focuses on developing innovative medical devices and therapies. With a market cap of $5 billion, it operates in the health care equipment sector, addressing critical health needs through advanced technology.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and drive sales.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

LIVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

In Q1-2026, LivaNova reported an EPS of $0.98, significantly beating estimates by 36.11%. The stock reacted positively, gaining 15.05% the following day.

Management Promises & Guidance

Continued focus on innovation in medical devices.
Commitment to improving operational efficiency.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about LivaNova's upcoming earnings, especially given its strong track record of beating EPS estimates.

Bull Case

If LivaNova continues its trend of exceeding EPS expectations, it could see significant stock price appreciation, especially if accompanied by positive revenue growth.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given LivaNova's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock movement.

What are the revenue expectations for the upcoming quarter?

Revenue growth is essential for assessing the company's overall health and future prospects, and any guidance on this will be closely watched.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate LivaNova's ability to sustain its earnings growth due to its innovative product pipeline and market expansion strategies.

Supporting Evidence

LivaNova has consistently beaten EPS estimates, indicating strong operational performance.

The options market is pricing a larger move than historical averages suggest, reflecting heightened uncertainty.

Past performance shows that the stock often reacts positively to earnings beats.

Key Risk

If LivaNova's revenue growth exceeds expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether LivaNova can maintain its strong earnings momentum in a competitive health care landscape.

Bull Confirmed If

An EPS of $1.10 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.80 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±21.07%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating uncertainty about the upcoming earnings report.

Options are pricing ±21.1% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

55.5%

Calls (200)P/C Ratio: 0.67Puts (400)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations, history suggests a potential stock increase of around 2.92%, confirming the company's growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of around 2.92%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Guidance on revenue growth for the next quarter.
3Management's outlook on market conditions and competition.
4Details on operational efficiencies and cost management.
5Insights into expansion plans in new markets.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing its costs and generating income.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its market presence and drive sales.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

LIVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

In Q1-2026, LivaNova reported an EPS of $0.98, significantly beating estimates by 36.11%. The stock reacted positively, gaining 15.05% the following day.

Management Promises & Guidance

Continued focus on innovation in medical devices.
Commitment to improving operational efficiency.
Plans to expand into new markets.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about LivaNova's upcoming earnings, especially given its strong track record of beating EPS estimates.

Bull Case

If LivaNova continues its trend of exceeding EPS expectations, it could see significant stock price appreciation, especially if accompanied by positive revenue growth.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, especially given the high implied volatility.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given LivaNova's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock movement.

What are the revenue expectations for the upcoming quarter?

Revenue growth is essential for assessing the company's overall health and future prospects, and any guidance on this will be closely watched.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate LivaNova's ability to sustain its earnings growth due to its innovative product pipeline and market expansion strategies.

Supporting Evidence

LivaNova has consistently beaten EPS estimates, indicating strong operational performance.

The options market is pricing a larger move than historical averages suggest, reflecting heightened uncertainty.

Past performance shows that the stock often reacts positively to earnings beats.

Key Risk

If LivaNova's revenue growth exceeds expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether LivaNova can maintain its strong earnings momentum in a competitive health care landscape.

Bull Confirmed If

An EPS of $1.10 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.80 would confirm the bear case and raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±21.07%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating uncertainty about the upcoming earnings report.

Options are pricing ±21.1% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

55.5%

Calls (200)P/C Ratio: 0.67Puts (400)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations, history suggests a potential stock increase of around 2.92%, confirming the company's growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of around 2.92%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations.
2Guidance on revenue growth for the next quarter.
3Management's outlook on market conditions and competition.
4Details on operational efficiencies and cost management.
5Insights into expansion plans in new markets.